Skip to content

Dr. Barbano Lucilla

Barbarano Lucilla
Linea di ricerca: Neuro-ophthalmology and neurophysiology of vision
Unità di ricerca: RU Neurophysiology of vision and neurophthalmology
Unità Operativa Semplice: CLINICAL CENTER OF NEURO-OPHTHALMOLOGY, GENETIC AND RARE DISEASES
Principali specializzazioni: GLAUCOMA, LOW VISION AND VISUAL REHABILITATION, OPTIC NERVE DISORDERS AND OPTIC TRACT DISORDERS, DIABETIC RETINOPATHY

Medical activity: Works at IRCCS G.B. Bietti  in the offices Via Livenza, 3 and  Via di santo Stefano Rotondo 6, at Presidio Ospedaliero Britannico, Rome

Scientific publication : PubMed

E-mail: lucilla.barbano@fondazionebietti.it

Degree in Medicine and Surgery  at the University of  Rome ‘La Sapienza’ in  2010. Specialization with  honours in Ophthalmology in July 2017 at the Catholic University of Sacred Heart in Rome.

During her training, she was able to gain clinical, surgical and scientific experiences. She participated to scientific works, clinical trials and congresses both nationally and internationally also as speaker with great interest for the diseases of posterior segment of the eye.  Since January 2018 she has been a researcher at IRCCS Fondazione Bietti in the Neurophysiology of vision and Neurophthalmology unit.

Ophthalmologist and researcher at the IRCCS G. B. Bietti Foundation

  • July 2021- December 2022: MGT-RPGR-023 (MeiraGTx UK II Ltd) “Study to determine the presence of patients with genetically confirmed RPGR-associated XLRP at research centers for potential participation in future clinical research studies”.

 

  • December 2016-2018-: SEQUOIA 150998-006 (Allergan). “Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients with Neovascular Age-Related Macular Degeneration”.

 

  • November 2013 – 2016: LOUMINOUS RFB002A2406 (Novartis): “Study to observe the efficacy and safety of Ranibizumab through personalized patient treatment and related results”.
Skip to content